SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-20-000692
Filing Date
2020-05-07
Accepted
2020-05-07 07:32:43
Documents
13
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K a52216255.htm   iXBRL 8-K 28123
2 EXHIBIT 99.1 a52216255ex99_1.htm EX-99.1 489171
  Complete submission text file 0001157523-20-000692.txt   688672

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crl-20200507.xsd EX-101.SCH 4186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crl-20200507_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crl-20200507_pre.xml EX-101.PRE 16825
6 EXTRACTED XBRL INSTANCE DOCUMENT a52216255_htm.xml XML 4083
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 20854584
SIC: 8731 Services-Commercial Physical & Biological Research